OKYO Pharma Bullish Thesis
OKYO Pharma's presentation highlights their key drug candidate, OK-101, developed to treat Dry Eye Disease (DED) and Neuropathic Corneal Pain (NCP).
Okyo Pharma Ltd (OKYO)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Woodline Partners Michael Rockefeller And Karl Kroeker | 3,652,190 | $5,880,026 | 0.02% | |
| 2. | Stonepine Capital Timothy P. Lynch | 850,000 | $1,368,500 | 0.55% | |
| 3. | Balyasny Asset Management Dmitry Balyasny | 584,796 | $941,522 | 0% | |
| 4. | Renaissance Technologies Jim Simons | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.50 | 16,670 | $25,005.00 | 16,670 | 2023-09-15 | Filing | |
| $0.08 | 5,800,000 | $440,800.00 | 548,981,215 | 2022-05-19 | Filing | |
| $4.00 | 12,500 | $50,000.00 | 12,500 | 2022-05-19 | Filing | |
| $4.00 | 37,500 | $150,000.00 | 62,500 | 2022-05-19 | Filing | |
| $3.87 | 25,000 | $96,750.00 | 25,000 | 2022-05-17 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,175,535 | $1,892,611 | 0.04% | |
| 2. | 59,760 | $96,214 | 0% | |
| 3. | 37,652 | $60,620 | 0% | |
| 4. | 12,812 | $20,627 | 0% | |
| 5. | 12,090 | $19,464 | 0% |
News See All
